Karuna Therapeutics inks new drug discovery deal (NASDAQ:KRTX

published 28.07.2020 11:45

Image of article 'Karuna Therapeutics inks new drug discovery deal (NASDAQ:KRTX'

Karuna Therapeutics (KRTX ) has agreed to partner with privately held PGI Drug Discovery LLC (PsychoGenics) to identify novel candidates for severe neuropsychiatric disorders.

Under the terms of the deal, Karuna will pay PsychoGenics an undisclosed upfront amount for access to its proprietary screening platforms that leverage computer vision and machine learning.

by Douglas W. House from seekingalpha.com

Free awesomeness straight to your inbox!

Sign up now for this free newsletter to receive hand picked content, covering topics like Lifestyle, Business & Technology.

Free Newsletter Sign up now!

..or jump directly to the latest posts!